![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 19, 14248-14254, May 12, 2000
From the Caspase-1 (interleukin-1
The Prodomain of Caspase-1 Enhances Fas-mediated Apoptosis
through Facilitation of Caspase-8 Activation*
§¶,
, and
Neuroscience and Immunology Research
Laboratories, Sankyo Co., Ltd., 1-2-58, Hiromachi, Shinagawa,
Tokyo 140-8710, Japan and the § University of Alabama at
Birmingham and the Birmingham Veterans Affairs Medical Center,
Birmingham, Alabama 35294-0007
converting enzyme) is
produced in the form of a latent precursor, which is cleaved to yield a
prodomain in addition to the p20 and p10 subunits. It has been
established that the (p20/p10)2 heterotetramer
processes the latent precursor of interleukin-1
into an active form
during apoptosis, but the function of the residual prodomain of
caspase-1 (Pro-C1) has not been established. To evaluate the
involvement of Pro-C1 in apoptosis, a Pro-C1 expression vector was
transfected into the HeLa cell line, which is susceptible to
Fas-mediated apoptosis. Expression of recombinant Pro-C1 in HeLa cells
enhanced apoptosis mediated by Fas, but not etoposide-induced
apoptosis. This enhancement of Fas-mediated apoptosis was abolished by
inhibitors of caspase-8 (Ile-Glu-Thr-Asp-fluoromethyl ketone) and
caspase-3 (Asp-Glu-Val-Asp-aldehyde) but was only slightly diminished
by an inhibitor of caspase-1 (acetyl-Tyr-Val-Ala-Asp-chloromethyl
ketone). During apoptosis induced by an agonistic anti-Fas antibody,
the activation of caspase-8 and caspase-3 was more pronounced and
occurred more rapidly in HeLa/Pro-C1 cells than in the empty vector
transfectant (HeLa/vec) cells; in contrast, caspase-1 was not activated
in either HeLa/Pro-C1 or HeLa/vec cells. These results demonstrate an
additional and novel function for caspase-1 in which Pro-C1 acts to
enhance Fas-mediated apoptosis, most probably through facilitation of
the activation of caspase-8.
*
This work was supported by funds from the Sankyo Co., Ltd.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
M. Sarai, D. Hartung, A. Petrov, J. Zhou, N. Narula, L. Hofstra, F. Kolodgie, S. Isobe, S. Fujimoto, J.-L. Vanderheyden, et al. Broad and Specific Caspase Inhibitor-Induced Acute Repression of Apoptosis in Atherosclerotic Lesions Evaluated by Radiolabeled Annexin A5 Imaging J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2305 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Syed, H. S. Hahn, A. Odley, Y. Guo, J. G. Vallejo, R. A. Lynch, D. L. Mann, R. Bolli, and G. W. Dorn II Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial Ischemia Circ. Res., May 27, 2005; 96(10): 1103 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Selleri, J. P. Maciejewski, N. Montuori, P. Ricci, V. Visconte, B. Serio, L. Luciano, and B. Rotoli Involvement of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis in chronic myeloid leukemia cells Blood, August 15, 2003; 102(4): 1490 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Choi, O. Kutsch, J. Park, T. Zhou, D.-W. Seol, and E. N. Benveniste Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Induces Caspase-Dependent Interleukin-8 Expression and Apoptosis in Human Astroglioma Cells Mol. Cell. Biol., February 1, 2002; 22(3): 724 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Martin and A. Panja Cytokine regulation of human intestinal primary epithelial cell susceptibility to Fas-mediated apoptosis Am J Physiol Gastrointest Liver Physiol, January 1, 2002; 282(1): G92 - G104. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Hansen-Hagge, U. Trefzer, A. S. zu Reventlow, K. Kaltoft, and W. Sterry Identification of sample-specific sequences in mammalian cDNA and genomic DNA by the novel ligation-mediated subtraction (Limes) Nucleic Acids Res., February 15, 2001; 29(4): e20 - e20. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Winter, A. Kramer, A. Borkowski, and N. Kyprianou Loss of Caspase-1 and Caspase-3 Protein Expression in Human Prostate Cancer Cancer Res., February 1, 2001; 61(3): 1227 - 1232. [Abstract] [Full Text] |
||||
![]() |
N. Droin, M. Beauchemin, E. Solary, and R. Bertrand Identification of a Caspase-2 Isoform that Behaves as an Endogenous Inhibitor of the Caspase Cascade Cancer Res., December 1, 2000; 60(24): 7039 - 7047. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |